Selection Bias and Baseline Imbalances in Randomized Trials Vance W. Berger Correspondence 30 December 2004 Pages: 1 - 2
Selection Bias and Baseline Imbalances in Randomized Trials Damian J. McEntegart Correspondence 30 December 2004 Pages: 3 - 4
An Endpoint for Worsening Asthma: Development of a Sensitive Measure and its Properties Ji ZhangCindy SongTheodore F. Reiss Clinical and Non-Clinical Drug Development 30 December 2004 Pages: 5 - 13
The Use of the World Health Organisation Anatomical Therapeutic Chemical/Defined Daily Dose Methodology in Canada Ingrid S. SketrisColleen J. MetgeJim L. Blackburn Clinical and Non-Clinical Drug Development 30 December 2004 Pages: 15 - 27
The Regulation and Approval of New Drugs in China Rongling DengKenneth I Kaitin Drug Regulation 30 December 2004 Pages: 29 - 39
An Application of Markov Models in Estimating Transition Probabilities for Postmenopausal Women with Osteoporosis Zhengqing LiSimon Pack Statistics 30 December 2004 Pages: 41 - 46
Biostatistical Design and Analyses of Long-Term Animal Studies Simulating Human Postmenopausal Osteoporosis Ludwig A. HothornFrieder Bauss Statistics 30 December 2004 Pages: 47 - 56
Pharmacoepidemiology in Safety Evaluations of Newly Approved Medications Elane M. Gutterman Drug Safety 30 December 2004 Pages: 61 - 67
The National Library of Medicine and Drug Information. Part 1: Present Resources James E. KnobenSteven J. PhillipsMartha R. Szczur Drug Information 30 December 2004 Pages: 69 - 81
Evaluating the Balance of Persuasive and Informative Content within Product-Specific Print Direct-to-Consumer Ads Erin R. HolmesShane P. Desselle Medical Communication 30 December 2004 Pages: 83 - 98